Dynamic Monitoring of Cytotoxicity on Microelectronic Sensors

Curren R., 1998, 13th meeting of the Scientific Group on Methodologies for the Safety Evaluation of Chemicals (SGOMSEC):  Validation and acute toxicity testing. Environ. Health Perspect. 106 (Suppl. 2), 419−425

Ekwall, B., and Sjostrom, M. (2000) MEIC evaluation of acute systemic toxicity. Part VIII. Multivariate partial least squares evaluation, including the selection of a battery cell line tests with a good prediction of human acute lethal peak blood concentrations for 50 chemicals.ATLA28(Suppl. 1), 201−234.

NIEHS, NIH, U.S. Public Health Service and Department of Health and Human Services (2001)Guidance Document on Using in Vitro Data to Estimate in Vivo Starting Doses for Acute Toxicity, NIH Publication 01-4500, NIEHS, North Carolina.

Spielmann H., 2002, ATLA, 30, 40

Zucco F., 2004, Vitro 18, 153−163.

Voskoglou-Nomikos T., 2003, Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models. Clin. Cancer Res. 9, 4227−4239

Pichler W. J., 2001, Toxicology, 158, 41, 10.1016/S0300-483X(00)00399-1

Davila J. C., 1998, Annu. Rev. Pharmacol. Toxicol., 38, 96, 10.1146/annurev.pharmtox.38.1.63

Willingham M. C., 1999, J. Histochem. Cytochem., 47

Barrett K. L., 2001, J. Histochem. Cytochem., 49, 10.1177/002215540104900703

Botham P. A., 2004, Vitro 18, 227−230.

Terris M. K., 2003, The effect of contrast material on transitional cell carcinoma viability. Adv. Exp. Med. Biol. 539, 121−128

Jaeschke H., 1996, Mechanisms of inflammatory liver injury:  Adhesion molecules and cytotoxicity of neutrophils. Toxicol. Appl. Pharmacol. 139, 213−226

Lindert K. A., 2000, Effect of contrast material on transitional cell carcinoma viability. Urology 56, 876−879

Vousden, K. H. (2002) Switching from life to death:  The Miz-ing link between Myc and p53.Cancer Cell. 2, 351−352.

Yang J., 2003, ATM, ATR and DNA-PK:  Initiators of the cellular genotoxic stress responses. Carcinogenesis 24, 1571−1580

Salazar G., 2003, Apoptosis in male germ cells in response to cyclin A1-deficiency and cell cycle arrest. Biochem. Pharmacol. 66, 1571−1579

Tsuruo T., 2003, Cancer Sci., 94, 21, 10.1111/j.1349-7006.2003.tb01345.x

Reid T., 1994, Circ. Shock., 44, 90

Srivastava R. K., 2001, TRAIL/Apo-2L:  Mechanisms and clinical applications in cancer. Neoplasia (New York) 3, 535−546

Xiao C., 2002, Assessment of cytotoxicity using electric cell-substrate impedance sensing:  Concentration and time response function approach. Anal. Chem. 74, 5748−5753

Hug T. S., 2003, Biophysical methods for monitoring cell-substrate interactions in drug discovery. Assay Drug Dev. Technol. 1, 479−488

Mei N., 2003, FASEB J., 17

Qian Y., 2003, J. Inorg. Biochem., 96, 10.1016/S0162-0134(03)00235-6

Chattopadhyay S., 2002, Toxicol. Lett., 28, 84

Kim S. H., 2003, Ca(2+) homeostasis, and cytokine gene expression. Toxicol. in Vitro 17, 385−395.

Herr H. W., 1981, J. Surg. Oncol., 18, 99

Bagchi, D., Bagchi, M., and Stohs, S. J. (2001) Chromium (VI)-induced oxidative stress, apoptotic cell death and modulation of p53 tumor suppressor gene.Mol. Cell. Biochem. 222, 149−158.